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The  antigens  recognized by the  human  cold-reactive autoantibodies  anti-I  and 
anti-i are distributed on a variety of cell types and in secretions (1-4). These antigens 
are known to occur on the carbohydrate chains that constitute the core structures of 
the  blood  group  ABH  antigens  (5,  6)  and  certain  erythrocyte gangliosides  (7,  8). 
Recently, we reported that  the straight chain glycosphingolipid lacto-N-norhexaosyl 
ceramide: 1 Galfll -0 4GIcNAcfll ~  3Galfll ---* 4GlcNAcfll --0 3 Galfll --0 4 Glcfl 
--0 Cer reacted with  five out  of six anti-i  antibodies  (7).  In contrast, the branched 
glycosphingolipid lacto-N-iso-octaosyl  ceramide: 
Galfll ---* 4GIeNAcfll "~6 
3Galfll --0 4GIcNAcfll ---* 3Galfll --0 4Cleft---* Cer 
Galfll ---* 4GlcNAcfll/~ 
reacted with all 5 anti-I antibodies tested but with only two out of six anti-i antibodies 
(9).  The I  and  i  activities of eight  analogues of lacto-N-iso-octaosyl  ceramide were 
compared and it was concluded that (a) the antigenic determinants recognized by the 
five anti-I antibodies tested are located on various domains within the branched lacto- 
N-iso-octaosyl structure and (b) the antigenic determinants recognized by four out of 
the  six  anti-i  antibodies  were  masked  by  the  presence of the  GIcNAcfll  --*  6Gal 
branch at the middle galactose residue of the i-active lacto-N-nor hexaosyl ceramide 
(9). 
This report is an analysis of the inhibitory activities in radioimmunoassays of lacto- 
N-iso-octaosyl  ceramide and  its 8 analogues  (9) with  11  anti-I sera, including the 5 
antisera previously tested.  10 of the anti-I antibodies were inhibited by the lacto-N- 
iso-octaosyl  structure.  Although  none  of the  anti-I  antibodies  was  identical  in  its 
reactivities  with  the  various  analogues;  three  main  patterns  of activity  could  be 
distinguished corresponding to recognition of three domains within  the lacto-N-iso- 
octaosyl ceramidc structure. 
* Supported by grants from the National Institutes of Health, CA 19924 and CA 20026. 
i Nomenclature according to the Commission on Biochemical Nomenclature of the International Union 
of Pure and Applied Chemistry. The use of the terms iso and nor has been explained previously (7). 
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Materials  and Methods 
E~ythrocyte Glycolipids.  The bovine erythroeyte ganglioside (structure I, Table I) with slow 
migrating properties on thin-layer chromatography was isolated and  its  structure was deter- 
mined by methylation analysis, direct probe mass spectrometry of the methylated ganglioside 
and of the methylated nonasaeeharide liberated by endo-fl-galactosidase of Escherichiafreundii, 
and by sequential degradation with various exoglycosidases as described previously (9). Eight 
glyeolipid  analogues  (structures  II  to  IX)  with  branched  and  unbranched  carbohydrate 
structures were prepared by sequential degradation of  the ganglioside with various combinations 
of exoglyeosidases (9). Anti-I cold agglutinins from patients Ma, Woj, Step, Gra, Ver, Ful, Phi, 
Da, Seh, Low, and Zg have been described previously (5,  10-12). 
Antigenic Analysis of the Glycolipids. The reaetivities of the glycolipids with the various anti-I 
sera were determined by radioimmunoassays as described previously (8, 13). Briefly, glyeolipids 
complexed with cholesterol and lecithin as carrier  lipids  (proportions of cholesterol, lecithin 
and glycolipids were 2:2:1 by weight) were used as inhibitors of the binding of the anti-I sera 
to a radioiodinated I- or (I + i)-active glycoprotein. The results were expressed as the minimum 
concentration of glycolipids giving 50% inhibition of binding. 
Results 
Table  I  shows  the  inhibitory  activities  of lacto-N-iso-octaosyl  ceramide  and  its 
analogues  with  the  anti-I  sera  Ver,  Ful,  Phi,  Da,  Low,  and  Zg  in  addition  to  the 
previously tested antisera Ma, Woj, Step, Gra, and Sch. With the exception of anti-I 
Zg, all  the antM  sera were inhibited  by structure  III. The I  activity of structure  III 
was abolished after removal of the two terminal fl-galactosyl residues to give lacto-N- 
iso-hexaosyl eeramide  (structure VI). 
A comparison of the reactions of the anti-I sera with structures I to IX indicate that 
none of the  11  antibodies  tested was identical  in the antigenic  determinants  that  it 
recognized.  However,  three  main  types  of reactivity  could  be  distinguished.  Anti-I 
sera  Ma  and  Woj  represent  the  first  type which  requires  the  1 --~  4,  1 --~  6  chain, 
although  the branched  structure  is  not  essential,  in  agreement  with  previous obser- 
vations (6, 9,  10). Anti-I sera Step, Gra, Ver, and Ful represent the second type which 
requires  predominantly the  1 ~  4,  1 ~  3 chain but, unlike the first type, the  1 ~  6 
branching structure is required for full expression of the I activity, except with anti-I 
Ver which reacts equally well with the branched and straight chain structures III and 
VIII, respectively.  The  third  type of anti-I  activity  is  represented  by sera  Da,  Sch, 
Low, and Phi which require both the  1 ~  4,  1 ~  6 and  1 ~  4,  1 --* 3 branches to be 
present  in the intact state as in structure III. Substitution of the terminal fl-galactosyl 
residues  of the  two  chains  with  a-galactose  or  sialic  acid  decreases  but  does  not 
necessarily abolish the I activity as seen with structures I and II. 
Discussion 
From these and previous studies with purified lacto-N-iso-octaosyl ceramide, lacto- 
N-nor-hexaosyl  ceramide  and  their  analogues  (7,  9),  crucial  information  has  been 
obtained on the molecular basis of I and i specificities and certain generalizations can 
now be made:  (a)  nonreducing terminal fl-galactose is an important part of both the 
I  and  i  antigenic  determinants;  (b)  an  intact  straight  chain  oligosaccharide  with  a 
repeating Galfll ~  4GIcNAcfll ~  3 sequence expresses the majority of i and part of 
I  antigenic  determinants;  (c)  the antigenic  determinants  recognized by the majority 
of anti-I-antibodies  are  expressed  on  intact  1 ~  4,  1 ~  6,  and/or  1 ---* 4,  1 --~  3 
branched structures. FEIZI  ET  AL.  BRIEF  DEFINITIVE  REPORT  977 
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The  present  studies  reveal  three  main  types of I  specificity at  the  same time as 
demonstrating  the  individuality  in  the  fine  specificity  of each  monoclonal  anti-I 
antibody.  The  dramatic  differences  between  anti-I  and  anti-i  cold  agglutinins  of 
different individuals in their hemagglutinating activities with erythrocytes of various 
Ii phenotypes and in their precipitation  reactions with various precursor-like glyco- 
proteins are well known.  These differences have been previously used to subclassify 
anti-I and anti-i antibodies into subtypes (10,  12).  However, classification based on 
reactions with complex reference materials such as glycoproteins and erythrocytes are 
difficult  to interpret,  because of the extreme heterogeneity of their oligosaccharide 
chains.  In  fact,  the  present  studies  with  the  purified  glycolipids  have  revealed 
considerable differences between the reactivities of anti-1 Step and those of Sch and 
Low, although the three antibodies had been assigned to the same group (anti-I group 
3) on the basis of their precipitation reactions with water soluble glycoproteins (10). 
Furthermore,  among the  four  anti-I  antibodies  which  require  the  intact  branched 
structure, as in structure III, are antibodies previously assigned to anti-I group 3 (Sch 
and Low), group 4  (Gra), and group 5 (Da)  (10). 
The ability of several anti-I antibodies to react with their antigenic determinants 
in  the  presence  of external  substitutions  (a-linked  galactose  or  sialic  acid)  is  an 
important consideration in the interpretation of the antigenicity of complex structures 
(or mixtures) and of the effects of digestion with/~-galactosidase (14). Substances rich 
in the carbohydrate sequences found in structures II, III, IV, and V  would lose much 
of  their  I  activity  after  /~-galactosidase  treatment.  However,  substances  rich  in 
structure I would retain their activities after such treatment. 
Thus far the antigenic determinants recognized by 2 of the 16 anti-I and anti-i cold 
agglutinins  (anti-I Zg and anti-i Galli)  are unknown.  The specificities of the others 
have been shown to involve one or other kind of type 2  precursor chain  (15),  i.e.  1 
4,  1 ~  3 and/or 6 sequences. It is interesting to speculate whether type  1 chains 
(15)  with  1 ~  3,  1 ~  3 sequence are involved in the specificities of Zg and Galli. So 
far, the branched or straight chain analogues of the 1 ~  4,  1 ~  3 sequence have been 
described  in  the  precursor chains  of blood  group  ABH-active glycolipids  (16)  and 
erythrocyte gangliosides (7, 9,  17), and among oligosaccharides isolated from human 
milk (18).  It would be predicted that these analogues also exist as precursor chains of 
secreted human blood group substances, for substantial I and i activities are found on 
ovarian cyst glycoproteins of persons who are nonsecretors (5,  10,  19). 
Summary 
Blood group I  activities of the purified glycosphingolipid lacto-N-iso-octaosyl  cer- 
amide 
Gal/~ 1 --) 4GlcNAc/~ 1 ",a 
6 Gal~l -* 4GIcNAc~I --~ 3Gal/~l --+ 4GIcB ~  Cer 
3 
Gal~l --* 4GIcNAc/~I/~ 
and 8 of its analogues have been evaluated with  11  anti-I sera including 5 anti-I sera 
previously tested. All but one of the antisera were inhibited by the lacto-N-iso-octaosyl 
structure.  Three  types of 1-specificity could  be distinguished  although  none  of the 
anti-I  sera was  identical  in  its  inhibition  patterns  with  the  nine  glycosphingolipid FEIZI ET  AL.  BRIEF DEFINITIVE REPORT  979 
analogues. The anti-I sera Ma and Woj represent the first type and require an intact 
Galfll ~  4GIcNAcfll ~  6 chain, the anti-I sera Step, Gra, Ver, and Ful represent the 
second type which requires Galfll --* 4GlcNAefll ---* 3 chain with branching, and the 
anti-I  sera  Phi,  Da,  Sch,  and  Low  belong  to  the  third  type  which  requires  both 
branches  to  be  intact.  Anti-I  antibodies  vary  in  their  ability  to  react  with  their 
antigenic determinants in the presence of external substitutions with a-linked galactose 
or sialic acid. 
Received  for publication 28 December 1978. 
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